Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/20/2012US8314104 Method of treating diabetes
11/20/2012US8314103 Pyridyl derivatives, their preparation and use
11/20/2012US8314102 Stable, crystalline (6S)-N(5)-methyl-5,6,7,8,-tetrahydrofolic acid
11/20/2012US8314101 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative
11/20/2012US8314100 1-[6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives
11/20/2012US8314099 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
11/20/2012US8314098 Pyrazolo-pyrimidine compounds
11/20/2012US8314097 Organic compounds
11/20/2012US8314096 Sigma receptor inhibitors
11/20/2012US8314095 [6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
11/20/2012US8314094 Benzoxazinone derivative
11/20/2012US8314093 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
11/20/2012US8314092 Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonists
11/20/2012US8314091 N-benzyl,N'-arylcarbonylpiperazine derivatives
11/20/2012US8314090 Methods of synthesis of benzazepine derivatives
11/20/2012US8314089 Substituted pyrazolamides and their use
11/20/2012US8314088 Pyrazinooxazepine derivatives
11/20/2012US8314087 Nitrogen-containing heterocyclyl ketones and methods of use
11/20/2012US8314086 Methods of treating hypertriglyceridemia
11/20/2012US8314085 Agent for overcoming resistance to anti-cancer agent
11/20/2012US8314084 Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues
11/20/2012US8314083 Non-sedating antihistamine injection formulations and methods of use thereof
11/20/2012US8314082 Stilbene derivatives for ADP-ribosyl cyclase inhibitors
11/20/2012US8314081 Bisphosphonate compounds
11/20/2012US8314080 Method of treating type I diabetes
11/20/2012US8314079 Hyaluronic acid oligosaccharide fractions and drugs containing the same
11/20/2012US8314078 Silver nanoparticles as anti-microbial
11/20/2012US8314077 Noncentral nervous system conditions
11/20/2012US8314076 Method for inhibiting scavenger receptor-A and increasing immune Response to antigens
11/20/2012US8314075 Compositions and methods for inhibiting expression of huntingtin gene
11/20/2012US8314074 Formulations comprising antisense nucleotides to connexins
11/20/2012US8314073 Cancer-cell-specific cell proliferation inhibitors
11/20/2012US8314071 Bioactive molecules from co-cultivation of microbes
11/20/2012US8314070 Osmoprotective complexes for prevention of intra-cellular dehydration in mammals
11/20/2012US8314067 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
11/20/2012US8314064 Administering choline cytidine 5-pyrophosphate which raises levels of uridine or uridine phosphate; improving memory, learning, cognition, synaptic transmission, synthesis/release of neurotransmitters, and increasing brain phospholipid levels; Alzheimer's disease
11/20/2012US8314059 Diabetic nephropathy therapies
11/20/2012US8314051 Method of preparing 1-methylcyclopropene and applying the same to plants
11/20/2012US8313930 Using presence of single nucleotide polymorphisms as evaluative tools in predicting skin cell proliferative disorders
11/20/2012US8313912 Cancer specific oligosaccharide sequences and use thereof
11/20/2012US8313770 Modifying drug release in suspensions of ionic resin systems
11/20/2012US8313769 Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
11/20/2012US8313767 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
11/20/2012US8313762 Flexible bioresorbable hemostatic packing and stent
11/20/2012US8313761 Mesoporous implants for administering substances and methods of producing implants
11/20/2012US8313760 Compositions and methods for coating medical implants
11/20/2012US8313758 Method of producing high alcohol content foaming compositions with silicone-based surfactants
11/20/2012US8313754 Ophthalmic compositions containing a synergistic combination of two polymers
11/20/2012US8313751 Compositions and methods for the prophylaxis or treatment of viral diseases
11/20/2012US8313749 genetic vaccines comprising a recombination activating gene (rag) nucleotide sequence, used to code polypeptides, for the prevention and/or treatment of periodontal diseases, caused by infection by Porphyromonas gingivalis
11/20/2012US8313744 Composition for the prevention and treatment of absence seizures comprising PKC agonist as an effective ingredient
11/20/2012US8313740 Methods for treating cancer with a recombinant MVA expressing HER-2
11/20/2012US8313738 Pharmaceutical composition for intracellular acidification with cis-urocanic acid
11/20/2012US8313734 Malodour counteracting composition
11/20/2012US8313732 Formoterol superfine formulation
11/20/2012CA2710054C Oil extract from a bivalve mollusc that is rich in n-acylethanolamides
11/20/2012CA2693180C Fused bicyclic compound
11/20/2012CA2649997C Compositions comprising phenylephrine and acetaminophen for treatment of respiratory illness
11/20/2012CA2634811C Novel modifications to 2-amino-4-(4-fluorobenzylamino) -1- ethoxycarbonyl-aminobenzene and processes for preparing said compound
11/20/2012CA2616971C A composition comprising an extract of red mold rice for treatment of alzheimer's disease
11/20/2012CA2596387C 18-membered macrocycles and analogs thereof
11/20/2012CA2585062C Identification of a jak2 mutation in polycythemia vera
11/20/2012CA2583699C Stat3 phosphorylation inhibitor and notch1 expression inhibitor
11/20/2012CA2577253C Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof
11/20/2012CA2563806C Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline
11/20/2012CA2558896C Methods for the treatment of tinnitus induced by cochlear excitotoxicity
11/20/2012CA2549675C Oxazolidinone-quinolone hybrid antibiotics
11/20/2012CA2540328C Compositions and methods of using lamellar bodies for therapeutic purposes
11/20/2012CA2539975C 9,10-.alpha.,.alpha.-oh-taxane analogs and methods for production thereof
11/20/2012CA2537559C Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
11/20/2012CA2533763C Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors
11/20/2012CA2530882C Use of n-alkanols as activators of the cftr channel
11/20/2012CA2529878C Pyrazole derivative, drug composition containing the same and production intermediate therefor
11/20/2012CA2520391C Novel cyclodextrin derivatives, method for the preparation thereof and use thereof for the solubilization of pharmacologically active substances
11/20/2012CA2496790C Plant extracts stimulating nitric oxide production and their use in the treatment of inflammation and related diseases
11/20/2012CA2492989C Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
11/20/2012CA2482687C Treatment of mesothelioma
11/20/2012CA2482466C Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
11/20/2012CA2380331C Multiple cytokine-antibody complexes
11/20/2012CA2318095C Methods of treating tardive dyskinesia and other movement disorders
11/15/2012WO2012155146A1 Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same
11/15/2012WO2012155066A2 Spiro-oxindole mdm2 antagonists
11/15/2012WO2012155063A1 Treating cancer with an hsp90 inhibitory compound
11/15/2012WO2012155062A1 Stable povidone-iodine compositions with steroids or non-steroidal anti-inflammatories
11/15/2012WO2012155053A1 Modified biotin-binding protein, fusion proteins thereof and applications
11/15/2012WO2012155007A1 Multiple antigen presenting immunogenic composition, and methods and uses thereof
11/15/2012WO2012154986A1 Implantable polymeric device for sustained release of sufentanil
11/15/2012WO2012154975A2 Nitric oxide/cgmp pathway inhibition of vla-4 related cell adhesion
11/15/2012WO2012154956A2 Anxiolytic effect of pterostilbene
11/15/2012WO2012154942A2 Ceramide anionic liposome compositions
11/15/2012WO2012154904A1 Tropolone compounds for treating or preventing retroviral infection
11/15/2012WO2012154893A1 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154892A1 Combinations of propiverine and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154888A1 Compounds for treating protein folding disorders
11/15/2012WO2012154885A2 Carbonic anhydrase targeting agents and methods of using same
11/15/2012WO2012154879A2 Autophagy inhibitors
11/15/2012WO2012154861A2 Cancer treatments
11/15/2012WO2012154837A2 The use of ketone esters for prevention of cns oxygen toxicity
11/15/2012WO2012154814A1 Compositions and methods for treating alzheimer's disease
11/15/2012WO2012154812A1 L-proline and citric acid co-crystals of (2s, 3r, 4r, 5s, 6r )- 2- (3- ((5- (4-fluorophenyl)thiophen-2-yl) methyl) -4-methylphenyl)-6- (hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
1 ... 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 ... 7860